Topics

Saniona AB: Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia

03:05 EDT 26 Mar 2020 | FinanzNachrichten

PRESS RELEASE March 26, 2020 Aims to develop innovative new treatment options for patients with schizophreniaSaniona may receive up to €76.5 million in milestones plus royalties on worldwide net sa...

Original Article: Saniona AB: Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia

NEXT ARTICLE

More From BioPortfolio on "Saniona AB: Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia"

Quick Search